Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cybin Inc N.CYBN

Alternate Symbol(s):  CYBN

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.


NEO:CYBN - Post by User

Comment by Walter333on Feb 10, 2022 10:10am
253 Views
Post# 34416236

RE:RE:Forget CYBN - FSD Pharma has drug to cure MS

RE:RE:Forget CYBN - FSD Pharma has drug to cure MS
Mil_Man54 wrote: Ignore this POS pumper for HUGE....he's a paid promoter who continuously posts paid PR for the company....and for him to claim that they have a cure for MS is beyond irresponsible and disgusting and an outright LIE....report him as I did!


1. Fsd sued for misrepresentation to it's shareholders resulting in 5.5 mil settlement https://thedeepdive.ca/fsd-pharma-ends-class-action-lawsuit-with-5-5-million-settlement/ 2. Massive RS https://thedeepdive.ca/fsd-pharma-announces-1-for-201-share-consolidation/ 3. Failed cannabis venture https://seekingalpha.com/article/4229384-fsd-pharma-trying-to-run-can-walk 4. Wazniak mention on Cameo https://youtu.be/rKG8TOcbl9E 5. AD and Zeeshan vote down a motion to abolish the class A class B share structure reinforcing their total control over the company leaving no voice for Class B shareholders other than themselves as to the direction of the company. https://www.newsfilecorp.com/release/81833/Concerned-Shareholders-Issue-Information-Circular-for-FSD-Pharma-Inc.-Shareholders-Meeting-Urge-Shareholders-to-Vote-Their-Shares-Using-the-Gold-Proxy 6. Offered David Rosenberg, aka(PowerAnubis) one of Davids new accounts since being booted off CEO.ca 300,000 options in PUMP(World-class Extractions) https://www.google.com/url?sa=t&source=web&rct=j&url=https://webfiles.thecse.com/World_Class_Extractions_files_CSE_Form_11_-_Notice_of_Proposed_Stock_Option_-_April_9_2019.pdf%3FtXQzRXt.333qw7qsieU7wjequxRn6tn.%3D&ved=2ahUKEwi-29yyq-T1AhUPHzQIHSGXD_kQFnoECAMQAQ&usg=AOvVaw0gEpLLB1Oozd67BRRukMni 7. FSD abandons PEA Covid trials in pursuit of Lucid, in which AD had prior personal self interests https://ir.fsdpharma.com/sec-filings/all-sec-filings/content/0001062993-21-008912/exhibit99-1.htm due your own extreme due diligence in regards to this company and the promoter David Rosenberg who promotes several of the CEO's companies on multiple social media platforms.
<< Previous
Bullboard Posts
Next >>